Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He ...

The Indianapolis pharma giant announced it will acquire Orna Therapeutics for $2.4 billion, putting Lily in the rat race to develop injectable, in vivo CAR-T therapies to eliminate the costly cell ...

In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza vaccine.

In a sudden reversal, the US Food and Drug Administration has agreed to review Moderna’s experimental mRNA influenza vaccine.

The move might at first sound like little more than a reduced hassle—and maybe reckless, since there was good evidence in ...

Foreign substances such as mold, hair, and silicon dioxide (silica) were found in COVID-19 vaccines, potentially introduced ...

A 2023 law championed by Republicans requires the CDC have a director confirmed by the Senate. For months, though, it’s had ...

Researchers suggest a vaccine could replace multiple jabs every year for seasonal respiratory infections and be on hand in the event of a new pandemic.

Just last week, the agency rejected Moderna’s initial application, citing flaws in the company’s research design.

Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.